Trial Outcomes & Findings for Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD) (NCT NCT01391832)

NCT ID: NCT01391832

Last Updated: 2024-01-22

Results Overview

The primary outcome measure of treatment efficacy for post-traumatic stress disorder (PTSD) will be change in the Clinician Administered Post-Traumatic Stress Disorder Scale (CAPS) Total Severity Score (i.e., summed across frequency and intensity ratings for the 17 PTSD assessment items) from baseline at 1-month post-treatment. CAPS Total Severity Score ranges from 0 to 136. Difference scores were calculated as the outcome score minus the baseline score, with negative scores indicating a reduction in symptom severity from baseline (i.e., a positive treatment outcome), and differences between treatment groups in change scores were evaluated using t-tests.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

103 participants

Primary outcome timeframe

Outcome measures will be measured as change from baseline at 1-, 3-, and 6-month follow-ups

Results posted on

2024-01-22

Participant Flow

Veterans previously deployed to combat regions from 2001 to present (e.g., Operation Enduring Freedom (OEF), Operation Iraq Freedom (OIF), and Operation New Dawn (OND) with current combat-related PTSD symptoms were recruited from the community.

Participant milestones

Participant milestones
Measure
Sham rTMS
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) Repetitive Transcranial Magnetic Stimulation (rTMS): For the sham rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp and does not down modulate the right frontal lobe. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been alte
Active rTMS
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma. Repetitive Transcranial Magnet Stimulation (rTMS): For the active rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the active mode. After motor threshold determination, the stimulator coil is positioned over the dorsolateral prefrontal cortex - D
Overall Study
STARTED
49
54
Overall Study
1 Month Follow-Up
30
31
Overall Study
3 Month Follow-Up
28
29
Overall Study
COMPLETED
28
31
Overall Study
NOT COMPLETED
21
23

Reasons for withdrawal

Reasons for withdrawal
Measure
Sham rTMS
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) Repetitive Transcranial Magnetic Stimulation (rTMS): For the sham rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp and does not down modulate the right frontal lobe. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been alte
Active rTMS
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma. Repetitive Transcranial Magnet Stimulation (rTMS): For the active rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the active mode. After motor threshold determination, the stimulator coil is positioned over the dorsolateral prefrontal cortex - D
Overall Study
Withdrawal by Subject
21
22
Overall Study
Lost to Follow-up
0
1

Baseline Characteristics

Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sham rTMS
n=49 Participants
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) Repetitive Transcranial Magnetic Stimulation (rTMS): For the sham rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp and does not down modulate the right frontal lobe. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma.
Active rTMS
n=54 Participants
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma. Repetitive Transcranial Magnet Stimulation (rTMS): For the active rTMS with CPT group, the rTMS coil was be placed over over the dorsolateral prefrontal cortex - DLPFC (Brodmann Area 9/46) and stimulation provided at 1 Hz (1.5-2.0 Tesla strength, 100 - 300 microseconds.
Total
n=103 Participants
Total of all reporting groups
Age, Continuous
32.39 years
STANDARD_DEVIATION 6.13 • n=99 Participants
32.89 years
STANDARD_DEVIATION 7.60 • n=107 Participants
32.65 years
STANDARD_DEVIATION 6.91 • n=206 Participants
Sex: Female, Male
Female
5 Participants
n=99 Participants
1 Participants
n=107 Participants
6 Participants
n=206 Participants
Sex: Female, Male
Male
44 Participants
n=99 Participants
53 Participants
n=107 Participants
97 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants
n=99 Participants
13 Participants
n=107 Participants
22 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
40 Participants
n=99 Participants
41 Participants
n=107 Participants
81 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
White
42 Participants
n=99 Participants
42 Participants
n=107 Participants
84 Participants
n=206 Participants
Race/Ethnicity, Customized
African American
6 Participants
n=99 Participants
7 Participants
n=107 Participants
13 Participants
n=206 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=99 Participants
5 Participants
n=107 Participants
6 Participants
n=206 Participants
Region of Enrollment
United States
49 participants
n=99 Participants
54 participants
n=107 Participants
103 participants
n=206 Participants

PRIMARY outcome

Timeframe: Outcome measures will be measured as change from baseline at 1-, 3-, and 6-month follow-ups

Population: Veterans previously deployed to combat regions from 2001 to present (e.g., Operation Enduring Freedom (OEF), Operation Iraq Freedom (OIF), and Operation New Dawn (OND)) with current combat-related PTSD symptoms were recruited from the community. 103 were enrolled and randomly assigned to the treatment arms on a parallel 1:1 basis.

The primary outcome measure of treatment efficacy for post-traumatic stress disorder (PTSD) will be change in the Clinician Administered Post-Traumatic Stress Disorder Scale (CAPS) Total Severity Score (i.e., summed across frequency and intensity ratings for the 17 PTSD assessment items) from baseline at 1-month post-treatment. CAPS Total Severity Score ranges from 0 to 136. Difference scores were calculated as the outcome score minus the baseline score, with negative scores indicating a reduction in symptom severity from baseline (i.e., a positive treatment outcome), and differences between treatment groups in change scores were evaluated using t-tests.

Outcome measures

Outcome measures
Measure
Sham rTMS
n=49 Participants
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) The rTMS coil will be placed over the right prefrontal scalp region, simulating targeting DLPFC (Brodmann Area 9/46), with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access memory of the traumatic event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself, about self and the world which have been altered.
Active rTMS
n=54 Participants
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex The rTMS coil will be placed over the right prefrontal scalp region, targeting DLPFC (Brodmann Area 9/46), with the MagStim Rapid Stimulator set to the active mode. Alternating current turned on and off rapidly produces magnetic pulses (1.5-2.0 Tesla strength) that last for 100 - 300 microseconds (1 HZ at 110% of motor-threshold). Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access memory of the traumatic event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself, about self and the world which have been altered.
Change From Baseline to Follow-up in Clinician Administered Post-Traumatic Stress Disorder Scale Total Severity Score
1 month change from baseline
-35.59 change in scale score from baseline
Standard Error 4.22
-44.164 change in scale score from baseline
Standard Error 3.8226
Change From Baseline to Follow-up in Clinician Administered Post-Traumatic Stress Disorder Scale Total Severity Score
3 month change from baseline
-33.19 change in scale score from baseline
Standard Error 4.24
-44.95 change in scale score from baseline
Standard Error 3.85
Change From Baseline to Follow-up in Clinician Administered Post-Traumatic Stress Disorder Scale Total Severity Score
6 month change from baseline
-36.31 change in scale score from baseline
Standard Error 4.24
-47.76 change in scale score from baseline
Standard Error 3.82

SECONDARY outcome

Timeframe: Outcomes will be assessed at baseline and 6-month follow-up

Population: Sixty participants (6 female) of the 103 completed the study protocol and returned for 6-month follow-up evaluation; the data from those 60 veterans were analyzed and reported.

The secondary outcome measures will be a) the ERP measures of P3a amplitude for hyperarousal to combat threatening stimuli will be compared from post- to pre-treatment b) the total CAPS scores from pre-treatment and post-treatment will be compared.

Outcome measures

Outcome measures
Measure
Sham rTMS
n=28 Participants
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) The rTMS coil will be placed over the right prefrontal scalp region, simulating targeting DLPFC (Brodmann Area 9/46), with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access memory of the traumatic event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself, about self and the world which have been altered.
Active rTMS
n=32 Participants
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex The rTMS coil will be placed over the right prefrontal scalp region, targeting DLPFC (Brodmann Area 9/46), with the MagStim Rapid Stimulator set to the active mode. Alternating current turned on and off rapidly produces magnetic pulses (1.5-2.0 Tesla strength) that last for 100 - 300 microseconds (1 HZ at 110% of motor-threshold). Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access memory of the traumatic event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself, about self and the world which have been altered.
Changes in ERP/CAPS Cluster Scores Signals From Pre-Treatment to Post-Treatment
-1.2754 micro-volts
Standard Deviation 3.095
-0.6088 micro-volts
Standard Deviation 2.278

Adverse Events

Sham rTMS

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Active rTMS

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Sham rTMS
n=49 participants at risk
Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment) Repetitive Transcranial Magnetic Stimulation (rTMS): For the sham rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp and does not down modulate the right frontal lobe. Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma.
Active rTMS
n=54 participants at risk
Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex Cognitive Processing Therapy (CPT): CPT is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma. Repetitive Transcranial Magnet Stimulation (rTMS): For the active rTMS with CPT group, the rTMS coil was be placed over over the dorsolateral prefrontal cortex - DLPFC (Brodmann Area 9/46) and stimulation provided at 1 Hz (1.5-2.0 Tesla strength, 100 - 300 microseconds.
General disorders
Headache
2.0%
1/49 • Number of events 1 • 10 months
Two participants assigned to receive rTMS and one participant assigned to receive sham rTMS reported headaches and requested termination of the rTMS portion of the therapy.
3.7%
2/54 • Number of events 2 • 10 months
Two participants assigned to receive rTMS and one participant assigned to receive sham rTMS reported headaches and requested termination of the rTMS portion of the therapy.

Additional Information

Dr. John Hart, Jr.

University of Texas at Dallas

Phone: 972-883-4853

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place